You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 17, 2025

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
Nurit Keinan1, Ye'ela Scharff1, Oron Goldstein1
1The Shraga Segal Department for Microbiology, Immunology, and Genetics, Faculty of Health Sciences; National Institute for Biotechnology in the Negev, the Ben-Gurion University of the Negev, Beer-Sheva, POB 84105, Israel.
Researchers developed new mouse models for leukemia, including acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL). These immunocompetent models enable rigorous testing of novel anti-cancer therapies and study of malignancy mechanisms.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: